3 Recruiting Urinary Bladder Neoplasms Phase 2 Clinical Trials
Active phase 2 studies for urinary bladder neoplasms enrolling across the USA. Verify eligibility and contact site coordinators.
All Urinary Bladder Neoplasms studiesPhase 2 Studies for Urinary Bladder Neoplasms
🔵 Active, Not Recruiting Phase2
A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)
📍 Research Site — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guérin Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy
📍 Del Sol Research Management, LLC — Tucson, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase2
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
📍 Michael G Oefelein Clinical Trials ( Site 0138) — Bakersfield, California
View Study & Checklist ➔